Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of daprodustat versus erythropoietin injection for anemia in non-dialysis chronic kidney disease
CTR20254384Phase 3Active
- Sponsor
- Bocimed Pharmaceutical
- Start
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daprodustat, erythropoietin in anemia of chronic kidney disease, sponsored by Bocimed Pharmaceutical. Started Sep 2026; status: active.
02
Drugs
daprodustaterythropoietin
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on CTR20254384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254384.